60 Gracechurch Street
6th Floor
London EC3V 0HR
United Kingdom
44 20 3934 6630
https://www.cizzlebiotechnology.com
Settore/i: Healthcare
Settore: Biotechnology
Impiegati a tempo pieno: 4
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Mr. Allan John Syms | Executive Chairman | N/D | N/D | 1956 |
Prof. Dawn Coverley | Founder, Chief Scientific Officer & Non-Executive Director | N/D | N/D | 1965 |
Mr. Nigel R. Lee | Finance Director & Executive Director | N/D | N/D | 1961 |
Mr. Morgan Williams | Head of Commercialisation for Yorkshire Cancer Research and Board Observer | N/D | N/D | N/D |
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.
L'ISS Governance QualityScore di Cizzle Biotechnology Holdings Plc al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.